I propose to address briefly two important IP questions from an economic perspective: patented drug pricing in an international context and trade secret protection for health care outcomes. The first will involve some algebra; the second involves a bit of common sense that so far seems to have eluded us.
Dratler, Jay Jr.
"IP and Health Care: New Drugs Pricing and Medical Mistakes,"
Akron Intellectual Property Journal: Vol. 7
, Article 1.
Available at: https://ideaexchange.uakron.edu/akronintellectualproperty/vol7/iss1/1